Page last updated: 2024-09-05

sorafenib and Paraneoplastic Syndromes

sorafenib has been researched along with Paraneoplastic Syndromes in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gerber, JM; Grunwald, MR; Induru, R; McDonnell, MH1
Apostolidis, L; Horstmann, S; Jäger, D; Kahlert, C; Lordick, F; Siegmund, A; Thom, R1
Adamus, G; Anitori, R; Golchet, P; Jampol, LM; Mets, RB; Shaw, J; Wilson, D1

Reviews

1 review(s) available for sorafenib and Paraneoplastic Syndromes

ArticleYear
Cutaneous manifestations in leukemia patients.
    Seminars in oncology, 2016, Volume: 43, Issue:3

    Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Clofarabine; Cytarabine; Dermatomycoses; Etoposide; Humans; Leukemia; Mastocytosis; Niacinamide; Paraneoplastic Syndromes; Phenylurea Compounds; Skin Diseases, Bacterial; Skin Neoplasms; Sorafenib

2016

Other Studies

2 other study(ies) available for sorafenib and Paraneoplastic Syndromes

ArticleYear
Remission of paraneoplastic dermatomyositis associated with hepatocellular carcinoma under prednisolone and azathiopin, and concommittant sorafenib.
    Onkologie, 2009, Volume: 32, Issue:1-2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Benzenesulfonates; Carcinoma, Hepatocellular; Dermatomyositis; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Paraneoplastic Syndromes; Phenylurea Compounds; Prednisolone; Pyridines; Remission Induction; Sorafenib; Treatment Outcome

2009
Bilateral diffuse uveal melanocytic proliferation with a positive ophthalmoscopic and visual response to plasmapheresis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2011, Volume: 129, Issue:9

    Topics: Aged; Autoantibodies; Benzenesulfonates; Carcinoma, Bronchogenic; Cell Proliferation; Eye Proteins; Fatal Outcome; Fluorescein Angiography; Functional Laterality; Humans; Lung Neoplasms; Male; Melanocytes; Niacinamide; Ophthalmoscopy; Paraneoplastic Syndromes; Phenylurea Compounds; Plasmapheresis; Pyridines; Retina; Sorafenib; Tomography, Optical Coherence; Uveal Diseases; Visual Acuity; Visual Fields

2011